Plataforma MammaPrint® BluePrint® En el Cáncer de Mama Precoz - page 8

BCSS: breast cancer specific survival

Knauer M et al. Breast Cancer Res Treat. 2010. 120(3):655-61

Valor predictivo de la firma genética: Supervivencia libre de recaída metastásica

Metanálsis n=541

T1-T3, N0/N1

58% TAM 42% TAM + QT

MammaPrint

Valor predictivo

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1,2,3,4,5,6,7 9,10,11,12,13,14,15,16,17,18,...20